Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00470236
What this trial is testing

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

Who this might be right for
Carcinoma, Ductal, Breast
Trans Tasman Radiation Oncology Group 1,608
Post-approval studies (Phase 4)WithdrawnNCT04730609
What this trial is testing

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

Who this might be right for
ShiveringDose Finding Study
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT00099879
What this trial is testing

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01288469
What this trial is testing

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Sanofi 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT05363631
What this trial is testing

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Who this might be right for
Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Metastatic
Mohammed Milhem 55
Large-scale testing (Phase 3)Study completedNCT04674332
What this trial is testing

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Who this might be right for
Long Acting Insulin in Control of Gestational Diabetes Mellitus
Ain Shams University 148
Early research (Phase 1)Study completedNCT02052934
What this trial is testing

Safety of Sublingual dmLT for ETEC

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT00779545
What this trial is testing

Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)

Who this might be right for
Rhinitis, Allergic, Perennial
Organon and Co 455
Testing effectiveness (Phase 2)Study completedNCT02654860
What this trial is testing

Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia

Who this might be right for
Phase 1: Pain ManagementPhase 2: Pain Management
Sintetica SA 69
Not applicableStudy completedNCT01689155
What this trial is testing

Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 116
Post-approval studies (Phase 4)Looking for participantsNCT05648591
What this trial is testing

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Who this might be right for
SchizophreniaBipolar I Disorder
Vanda Pharmaceuticals 100
Post-approval studies (Phase 4)Study completedNCT00875485
What this trial is testing

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 210
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Testing effectiveness (Phase 2)Study completedNCT00370292
What this trial is testing

Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 19
Testing effectiveness (Phase 2)UnknownNCT05280275
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 36
Large-scale testing (Phase 3)Study completedNCT00091572
What this trial is testing

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 859
Testing effectiveness (Phase 2)Study completedNCT06602531
What this trial is testing

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Who this might be right for
Influenza, Human
Arcturus Therapeutics, Inc. 212
Testing effectiveness (Phase 2)Ended earlyNCT05678257
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Adenocarcinoma+2 more
NuCana plc 180
Large-scale testing (Phase 3)Study completedNCT03384589
What this trial is testing

CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Who this might be right for
Invasive Pneumococcal Disease, Protection AgainstStreptococcus Pneumoniae Infection
University of British Columbia 248
Testing effectiveness (Phase 2)Study completedNCT04969276
What this trial is testing

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 306
Next Page